asfotase alfa Injection 18 mg, 28 mg, 40 mg, 80 mg
Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
EU GMP
Manufacturer #20943
Established in 1954, this Manufacturer is a CTD dossier owner and manufacturer with a global presence spanning over 15 countries and regions. With a workforce of approximately 1,000 employees, it operates GMP-certified facilities in South Korea, producing tablets, capsules, and injectable formulations. As a GMP manufacturer, it holds certifications such as PIC/S GMP and EU GMP compliance. The Manufacturer's commitment to excellence as a CTD dossier owner and manufacturer and GMP manufacturer solidifies its reputation in the global pharmaceutical market.
Manufacturer usually replies in 31 days
None